Research Options:
Week of Expected Pricing Pending
Company Name Shangri-la tibetan pharmaceuticals, Inc.
Proposed Ticker TBET
CUSIP G80649109
Business Description A specialty pharmaceutical company focusing on the research,development, manufacturing and marketing of modernized traditional Tibetan medicines.
Lead Underwriter Anderson & Strudwick, Incorporated
Co-Managers N/A
Initial Shares 1,875,000
Revised Initial Shares N/A
Initial Price $7.50-$8.50
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.